1 Min Read
Nov 29 (Reuters) - PharmaLundesis AB:
* SAID ON WEDNESDAY EUROPEAN PATENT OFFICE EPO ISSUED LETTER OF INTETNT FOR IODOCARB COMP
Source text: bit.ly/2Qs1Mfz
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.